Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
Full article >>
Tuesday, June 30, 2009
New Take On Growth Factor Signaling In Tamoxifen Resistance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment